YBX3 and breast carcinoma: In breast cancer, NGR1 can regulate the expression of CCND2 and YBX3 to inhibit breast cancer angiogenesis and slow down the progression of breast cancer [15], but NGR1’s ferroptosis-associated neighborhood has not been reported.